PRESS-RELEASE ·Filed Mar 4, 2026
Press release: earnings
Actionable Insight • Neutral
Traders should await the actual earnings release and call for material data. No trading action is warranted based on this announcement alone.
Final — all horizons settled through T+60d
CTMX ▼ -26.82% at T+60d
NEUTRAL call ✗ call lost -26.82% · α vs SPY -36.91% · entry $5.07 → $3.71
T+1d
-5.92%
call -5.92% · α -5.34%
$4.77
settled 7mo ago
T+5d
-3.75%
call -3.75% · α -2.41%
$4.88
settled 7mo ago
T+20d
-10.06%
call -10.06% · α -5.64%
$4.56
settled 6mo ago
T+60d
-26.82%
call -26.82% · α -36.91%
$3.71
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
CytomX Therapeutics announced it will report full year 2025 financial results on March 16, 2026, before markets open, followed by a conference call. The press release contains no financial data, forward-looking results, or operational updates beyond the announcement of the earnings event.
Key Facts
- CytomX Therapeutics (CTMX) will report full year 2025 financial results on March 16, 2026, before market open.
- Company will host a conference call and webcast at 8:00 a.m. ET / 5:00 a.m. PT on the same day.
- No financial results, guidance, or material operational updates were disclosed in this press release.
- The release serves solely as a scheduling announcement for upcoming earnings.
Financial Impact
No financial data disclosed
Risk Factors
- Earnings could miss expectations given lack of pre-announcement or positive signaling.
- Biotech stocks like CTMX often experience volatility around earnings, especially with no forward guidance provided.
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3249296 |
5 reports for CTMX
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Jun 22, 2026 14w ago | 8-K | $3.15 $2.77 | ▼ −12.22% | ▼ −15.47% | $2.58 (−18.25%) |
Mar 18, 2026 28w ago | Press Release | $4.40 $2.98 | ▼ −32.27% | ▼ −43.80% | $2.58 (−41.48%) |
Mar 16, 2026 28w ago | Press Release | $5.45 $2.98 | ▲ +45.32% | ▲ +55.18% | $2.58 (+52.75%) |
Mar 16, 2026 28w ago | Press Release | $6.75 $2.94 | ▼ −56.44% | ▼ −66.93% | $2.58 (−61.85%) |
Mar 4, 2026 30w ago | Press Release | $5.07 $3.71 | ▼ −26.82% | ▼ −36.91% | $2.58 (−49.21%) |
Showing 5 of 5
US Market Status
Market Open — Closes in 49m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access